Cite
HARVARD Citation
Pose, E. et al. (2020). Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet gastroenterology and hepatology. pp. 31-41. [Online].